Types of Estrogen Hormone Replacement Therapy (HRT)

What You'll Learn in This Article

Q: Does the way estrogen is delivered actually matter, or is estrogen just estrogen? A: It matters a lot. Whether estrogen travels through your digestive system, absorbs directly through your skin, or works right where it's applied affects your liver, your clotting risk, and how steady your hormone levels stay throughout the day.

Q: Why do some women do so much better on a patch than a pill? A: The patch bypasses the liver entirely, which means more stable hormone levels and fewer risks related to clotting and metabolism. For women with migraines, cardiovascular concerns, or anyone who just wants steady hormone delivery without a daily pill, the patch is often a better fit.

Q: My main issue is vaginal dryness and painful sex: do I really need systemic HRT? A: Not necessarily. Low-dose therapy applied directly to vaginal tissue can restore moisture, rebuild tissue health, and reduce recurring UTIs all with very little absorption into the rest of your body.

Q: Can a cream really replace a capsule? A: For many women, yes. Estradiol and progesterone creams applied to the skin bypass the digestive system and liver, and a metered pump dispenser ensures you're getting an accurate dose every time.

Q: How do I know which form of estrogen is right for me? A: It comes down to your symptoms, your health history, and your preferences. This article walks through every option so you can have a more informed conversation with your provider.

Systemic vs. Local Therapy: What's the Difference?

Before diving into specific forms, it helps to understand the two broad categories.

Systemic estrogen travels through your bloodstream and reaches your whole body. It's used for symptoms that affect you all over: hot flashes, night sweats, mood changes, sleep disruption, and bone loss.

Local (vaginal) estrogen stays mostly where you apply it at the low doses used vaginally, very little estrogen makes it into your bloodstream. Multiple large studies have confirmed no increased risk of heart disease, blood clots, or cancer with vaginal estrogen at these low doses. Systemic hormone therapy carries a well-characterized risk profile too, and for most healthy women under 60 or within ten years of menopause, that risk is also considered low. Vaginal estrogen is simply the more targeted option when symptoms are localized, not necessarily the safer one in absolute terms.

Many women end up using both (systemic therapy for whole-body symptoms and local therapy for vaginal and urinary ones) and that's completely fine. They work well together.

Systemic Estrogen Therapy

Used for moderate to severe whole-body symptoms of menopause.

1. Oral Estrogen (Pills and Capsules)

Examples: Estradiol, Premarin

How it works: You take it by mouth, it's absorbed through your digestive system, and it passes through your liver before entering your bloodstream. From there it circulates throughout your body.

Common side effects: Nausea, breast tenderness, bloating, headaches, and spotting or irregular bleeding if you still have a uterus. Some women also notice weight changes. If you take thyroid medication, your dose may need adjusting since oral estrogen can affect how your body processes thyroid hormone.

What to know about this route: Because oral estrogen passes through your liver first, it triggers some changes that other routes don't. Your liver produces more clotting proteins in response, which raises the risk of blood clots (also called venous thromboembolism, or VTE) compared to skin-based options. Oral therapy consistently raises triglycerides (a type of fat in the blood) by 5-15% and is more likely than other routes to cause gallbladder problems. The small increased stroke risk seen in large studies of oral estrogen has not been found with transdermal (skin-applied) options.

A good fit for: Women who prefer a simple daily pill and don't have significant risk factors for clotting, liver problems, or metabolic issues. One additional advantage is cost: oral estrogen tablets or capsules are cheaper than other forms of estrogen therapy.

2. Transdermal Estrogen - The Patch

Examples: Climara, Vivelle-Dot, Sandoz

How it works: You apply an adhesive patch to your skin (usually your abdomen, hip, or buttock) and estradiol absorbs directly into your bloodstream through the skin. Because it never passes through your liver, the downstream effects are very different from oral estrogen.

Common side effects: Breast tenderness, mild fluid retention, and headaches which are similar to oral estrogen. The most patch-specific issue is skin irritation where the patch sits; rotating where you apply it usually helps.

Why the patch has advantages: Skipping liver metabolism makes a meaningful difference. The patch produces more stable hormone levels throughout the day and doesn't trigger the clotting, triglyceride, or gallbladder effects that oral estrogen does. A large multi-center study called the ESTHER trial found no increased blood clot risk with transdermal estrogen, and multiple other studies have confirmed the same. In eleven clinical trials comparing the two routes, the patch actually decreased triglycerides by 5-30% while oral estrogen raised them.

The American College of Cardiology specifically recommends the patch over oral estrogen for women with obesity, high triglycerides, diabetes, high blood pressure, or metabolic syndrome (a cluster of conditions that raise heart disease risk).

A good fit for: Women over 40-50, migraine sufferers, smokers, and anyone with metabolic or cardiovascular risk factors. In addition, many women find the patch very convenient as you simply replace it twice a week.

3. Transdermal Gel or Spray

Examples: EstroGel, Divigel, compounded creams

How it works: You apply a small amount of gel, cream or spray to your arm or thigh each day. Like the patch, it absorbs through your skin and bypasses the liver,so it shares the same advantages as the patch when it comes to clotting and triglyceride effects.

Common side effects: Similar to the patch, this therapy can cause breast tenderness, mild bloating, occasional skin sensitivity. One thing to be aware of: there's a small risk of transferring estrogen to someone else (a partner or child) through skin contact before the gel has fully dried. Clinical guidance recommends not washing the area for 2-3 hours after applying.

Why some women prefer it: No adhesive and no patch to change. The dose is easy to adjust, and it disappears completely once dry. A good option if patches irritate your skin. In addition, some compound pharmacies, including Inflexxion Health’s, can produce a combination estrogen/progesterone cream that makes it very convenient, as most women will need to take progesterone along with their estrogen to protect their uterine lining.

Local (Vaginal) Estrogen Therapy

Used for vaginal and urinary symptoms. Very little is absorbed into the rest of your body.

4. Vaginal Cream

Example: Estrace and compounded estradiol vaginal creams

What it treats: Vaginal dryness, pain during sex, recurring UTIs, and urinary urgency. The cream works right where it's applied – it rebuilds the vaginal lining, restores natural moisture and pH, improves blood flow, and strengthens tissue elasticity. Local estrogen is considered the most effective treatment for these symptoms and clinical trials show that even very low doses make a real difference. The cream is delivered via a plastic applicator and the amount generally is about the size of a large chickpea. Patients start with a course of 10-14 nights in a row and then taper to 2-3 nights per week for maintenance.

Common side effects: Mild local irritation, discharge, or light spotting when you first start using it. These usually settle down as your tissue heals.

Important things to know: Because the dose is so low and absorption is minimal, your estrogen levels stay within the normal postmenopausal range. This makes it a safe option even for women who can't use systemic hormone therapy, including those with a history of heart disease, blood clots, or stroke. You also typically don't need to add progesterone when using low-dose vaginal estrogen, even if you still have a uterus.

5. Vaginal Tablet or Ring

Examples: Vagifem (tablet), Estring (ring)

How they work and why some women prefer them: Both deliver low-dose estradiol locally - the same benefits as the cream, just in a different format. Some women find them easier to use. The tablet is inserted with a small applicator; the ring sits in place and releases estradiol steadily for about 90 days before you replace it. Patient satisfaction with the ring is high because it's so low-maintenance. Just note: the low-dose Estring ring is not the same as Femring, which delivers systemic (whole-body) doses of estrogen. The vaginal ring does tend to be more expensive and may be harder to adjust the dose quickly.

Common side effects: Mild vaginal irritation, light discharge, and occasional spotting - consistent with other local vaginal options.

Shared Side Effects of Systemic Therapy

All systemic estrogen can cause breast tenderness, fluid retention, headaches, mood changes, and irregular bleeding if you have a uterus. The more serious risks, like blood clots and stroke, are real but rare, and they're significantly shaped by two factors: your age and how you take estrogen.

Starting HRT within 10 years of menopause and before age 60 is associated with a much more favorable risk profile than starting later. A review published in Circulation concludes that women under 60 with low cardiovascular risk who start HRT within 10 years of menopause onset have a favorable overall benefit-to-risk balance. And as covered in the patch section, blood clot risk is specifically tied to oral estrogen, transdermal options don't carry the same risk.

It's also worth knowing that the breast cancer fears that once surrounded HRT have been thoroughly re-examined, and the evidence no longer supports them. A review by one of the Women's Health Initiative's own lead investigators found that the original results were not statistically significant for breast cancer, and that the findings were incorrectly applied to all women regardless of age or how they took estrogen.

The estrogen-only arm of that same study, followed long-term, actually showed a 23% reduction in breast cancer incidence. Updated FDA guidance now reflects what the fuller body of research shows: HRT, used appropriately, does not increase breast cancer risk: and for women without a uterus who can take estrogen alone, the evidence points in the opposite direction. This is one of the most important shifts in women's health in recent decades, and it's one your provider should be factoring into any conversation about hormone therapy.

How to Choose the Right Form

Your best option depends on several things working together:

What's bothering you most? Hot flashes and night sweats need systemic therapy. Vaginal dryness, painful sex, and UTIs often respond fully to local therapy alone.

When did you hit menopause? As the ACC's Circulation review outlines, starting within 10 years of menopause and before age 60 puts you in the window where the benefits are clearest and the risks are lowest.

What's your health history? Blood clots, migraines, smoking, obesity, high triglycerides, diabetes, or high blood pressure all tip the balance toward transdermal over oral. Women with cardiovascular risk factors in particular do better with skin-applied estrogen.

How do you want to take it? Daily pill, twice-weekly patch, daily gel, or a ring you replace every three months, your lifestyle and preferences matter and your provider should factor them in.

How does your skin and stomach respond? If you have GI issues, skip oral. If patches irritate your skin, a gel or cream might be the answer.

Key Principles Your Provider Should Follow

These are the guidelines that evidence-based menopause care is built around, drawn from current clinical standards:

Take the time to adjust dose and delivery The goal is to relieve your symptoms with as little hormone as needed and in a way that makes it easy for you to follow the treatment plan. Your provider should start low and adjust based on how you feel rather than aim for a specific hormone level on a lab test.

Check in every year. What's right for you at 52 may not be right at 58. Your symptoms, health risks, and priorities can all shift, and your treatment should shift with them. There's also no hard rule that says you have to stop at a certain age.

Add progesterone if you have a uterus. Estrogen on its own causes the uterine lining to thicken over time, which raises the risk of uterine cancer. Adding progesterone prevents that. Micronized progesterone (a bioidentical form) is generally preferred over older synthetic versions. Research suggests it has a better safety profile and the added benefit of supporting sleep and mood. The exception is low-dose vaginal estrogen, which doesn't absorb enough to stimulate the uterine lining, so progesterone isn't needed.

Match the treatment to the symptom. Systemic therapy for whole-body symptoms. Local therapy for vaginal and urinary symptoms. Many women need both, and that's completely fine, they work well together.

References

Canonico, M., Oger, E., Plu-Bureau, G., Conard, J., Meyer, G., Lévesque, H., Trillot, N., Barrellier, M.-T., Wahl, D., Emmerich, J., & Scarabin, P.-Y. (2007). Hormone therapy and venous thromboembolism among postmenopausal women: Impact of the route of estrogen administration and progestogens: The ESTHER study. Circulation, 115(7), 840–845. https://doi.org/10.1161/CIRCULATIONAHA.106.642280

Cho, L., Kaunitz, A. M., Faubion, S. S., Hayes, S. N., Lau, E. S., Pristera, N., Scott, N., Shifren, J. L., Shufelt, C. L., Stuenkel, C. A., & Lindley, K. J. (2023). Rethinking menopausal hormone therapy: For whom, what, when, and how long? Circulation, 147(7), 597–610. https://doi.org/10.1161/CIRCULATIONAHA.122.061559

Crandall, C. J., Hovey, K. M., Andrews, C. A., Chlebowski, R. T., Stefanick, M. L., Lane, D. S., Shifren, J., Chen, C., Kaunitz, A. M., Cauley, J. A., & Wactawski-Wende, J. (2018). Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study. Menopause, 25(1), 11–20. https://doi.org/10.1097/GME.0000000000000954

Manson, J. E., & Kaunitz, A. M. (2016). Menopause management — Getting clinical care back on track. New England Journal of Medicine, 374(9), 803–806. https://doi.org/10.1056/NEJMp1514242

Mohammed, K., Abu Dabrh, A. M., Benkhadra, K., Al Nofal, A., Carranza Leon, B. G., Prokop, L. J., Montori, V. M., Faubion, S. S., & Murad, M. H. (2015). Oral vs transdermal estrogen therapy and vascular events: A systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism, 100(11), 4012–4020. https://doi.org/10.1210/jc.2015-2237

Nolan, B. J., Liang, B., & Cheung, A. S. (2021). Efficacy of micronized progesterone for sleep: A systematic review and meta-analysis of randomized controlled trial data. Journal of Clinical Endocrinology and Metabolism, 106(4), e942–e951. https://doi.org/10.1210/clinem/dgaa873

Prior, J. C., Fung, M., & Seifert-Klauss, V. (2023). Oral micronized progesterone for perimenopausal night sweats and hot flushes: A Phase III Canada-wide randomized placebo-controlled 4-month trial. Scientific Reports, 13, Article 12012. https://doi.org/10.1038/s41598-023-35826-w

Raz, R., & Stamm, W. E. (1993). A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. New England Journal of Medicine, 329(11), 753–756. https://doi.org/10.1056/NEJM199309093291102

Rzepecki, A. K., Murase, J. E., Juran, R., Fabi, S. G., & McLellan, B. N. (2019). Estrogen-deficient skin: The role of topical therapy. Journal of the American Academy of Dermatology, 81(6), 1498–1511. https://doi.org/10.1016/j.jaad.2019.04.052

U.S. Food and Drug Administration. (2026, February 12). FDA approves labeling changes to menopausal hormone therapy products [Press announcement]. https://www.fda.gov/news-events/press-announcements/fda-approves-labeling-changes-menopausal-hormone-therapy-products